Literature DB >> 7055214

Crotalaria-induced pulmonary hypertension. Uptake of 3H-thymidine by the cells of the pulmonary circulation and alveolar walls.

B O Meyrick, L M Reid.   

Abstract

Feeding with Crotalaria spectabilis seeds induces structural changes in the pulmonary arterial circulation characteristic of pulmonary hypertension: increased medial and adventitial thickness, the appearance of muscle in smaller arteries than normal, and reduction in the number of peripheral arteries. By autoradiographic techniques, after injection of 3H-thymidine into rats fed Crotalaria for 3, 7, 14, 21, 28, or 35 days, the contribution of hyperplasia to these changes has been assessed at two levels of the pulmonary artery--the hilum and the periphery. In the hilar pulmonary artery, a biphasic increase in labeling index (LI) is seen in each cell type. After 3 days of feeding, the medial smooth muscle cells show a slight but significant increase (1.5 times the control value), and, after 7 days, so do the adventitial fibroblasts (3 x) and the endothelial cells (EC) (2 x). After 14 days LI for all three cell types is again at control values, but after 21 days (wall thickness is no increased) each cell type shows at least a fivefold increase; by 35 days all are again near control levels. In the intra-acinar region, by 14 days, "newly" muscularized arteries are identified and increase in number and proportion up to 35 days; 3H-thymidine uptake is not evident in this cell type until 35 days have passed. The ECs of these arteries, however, show a striking increase in LI after 14 days as do those of the alveolar capillaries. The ECs of the intra-acinar veins show a biphasic response being increased after 7, 28, and 35 days. The present study has shown that Crotalaria ingestion induces hyperplasia and hypertrophy of pulmonary arterial cells at pre- and intra-acinar levels. The early increase in LI probably represents a response to the original cell injury, the later changes, a response to continuing damage or, in part, adaptation to the pulmonary hypertension now present.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7055214      PMCID: PMC1915960     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  The prevention of monocrotaline-induced right ventricular hypertrophy.

Authors:  R Huxtable; S Paplanus; J Laugharn
Journal:  Chest       Date:  1977-02       Impact factor: 9.410

2.  Arterial changes in Crotalaria spectabilis-induced pulmonary hypertension in rats.

Authors:  A Hislop; L Reid
Journal:  Br J Exp Pathol       Date:  1974-04

3.  Pulmonary oedema in rats given monocrotaline pyrrole.

Authors:  R Plestina; H B Stoner
Journal:  J Pathol       Date:  1972-04       Impact factor: 7.996

4.  Toxicity of pyrrolizidine alkaloids.

Authors:  A R Mattocks
Journal:  Nature       Date:  1968-02-24       Impact factor: 49.962

5.  Monocrotaline model of noncardiogenic pulmonary edema in dogs.

Authors:  W C Miller; D L Rice; R G Kreusel; C W Bedrossian
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1978-12

6.  Response of small pulmonary arteries to unilobar hypoxia and hypercapnia.

Authors:  M Kato; N C Staub
Journal:  Circ Res       Date:  1966-08       Impact factor: 17.367

7.  Pulmonary hypertension produced in rats by ingestion of Crotalaria spectabilis seeds.

Authors:  J M Kay; P Harris; D Heath
Journal:  Thorax       Date:  1967-03       Impact factor: 9.139

8.  Effects of monocrotaline pretreatment of rats on removal of 5-hydroxytryptamine and noradrenaline by perfused lung.

Authors:  C N Gillis; R J Huxtable; R A Roth
Journal:  Br J Pharmacol       Date:  1978-07       Impact factor: 8.739

9.  The effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study.

Authors:  B Meyrick; L Reid
Journal:  Lab Invest       Date:  1978-02       Impact factor: 5.662

10.  Fibrin thrombosis in monocrotaline pyrrole-induced cor pulmonale in rats.

Authors:  J L Lalich; W D Johnson; T J Raczniak; R C Shumaker
Journal:  Arch Pathol Lab Med       Date:  1977-02       Impact factor: 5.534

View more
  18 in total

Review 1.  Pathology of pulmonary hypertension.

Authors:  Rubin M Tuder; John C Marecki; Amy Richter; Iwona Fijalkowska; Sonia Flores
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

2.  Inhalation of chrysotile asbestos induces rapid cellular proliferation in small pulmonary vessels of mice and rats.

Authors:  P D McGavran; L B Moore; A R Brody
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

Review 3.  Plexiform Arteriopathy in Rodent Models of Pulmonary Arterial Hypertension.

Authors:  Brandon L Carman; Dan N Predescu; Roberto Machado; Sanda A Predescu
Journal:  Am J Pathol       Date:  2019-03-26       Impact factor: 4.307

Review 4.  The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?

Authors:  Natalie Hopkins; Paul McLoughlin
Journal:  J Anat       Date:  2002-10       Impact factor: 2.610

5.  Contribution of oxidative stress to pulmonary arterial hypertension.

Authors:  Vincent G Demarco; Adam T Whaley-Connell; James R Sowers; Javad Habibi; Kevin C Dellsperger
Journal:  World J Cardiol       Date:  2010-10-26

6.  The effects of monocrotaline pyrrole on cultured bovine pulmonary artery endothelial and smooth muscle cells.

Authors:  J F Reindel; R A Roth
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

7.  Pulmonary artery adventitial changes and venous involvement in primary pulmonary hypertension.

Authors:  I Chazova; J E Loyd; V S Zhdanov; J H Newman; Y Belenkov; B Meyrick
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

8.  Golgi, trafficking, and mitosis dysfunctions in pulmonary arterial endothelial cells exposed to monocrotaline pyrrole and NO scavenging.

Authors:  Jason Lee; Reuben Reich; Fang Xu; Pravin B Sehgal
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-07-31       Impact factor: 5.464

Review 9.  Reactive oxygen species in pulmonary vascular remodeling.

Authors:  Saurabh Aggarwal; Christine M Gross; Shruti Sharma; Jeffrey R Fineman; Stephen M Black
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

Review 10.  The adventitia: Essential role in pulmonary vascular remodeling.

Authors:  Kurt R Stenmark; Eva Nozik-Grayck; Evgenia Gerasimovskaya; Adil Anwar; Min Li; Suzette Riddle; Maria Frid
Journal:  Compr Physiol       Date:  2011-01       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.